OneSource Pharma Raises FY28 Revenue Target to $500M
OneSource Pharma hikes FY28 revenue guidance to over $500 million, plans $100M expansion for weight-loss drugs like semaglutide. CEO reveals accelerated growth strategy.
Category : Search result: MSME pharma
MSMEs Seek Loan Moratorium Over US Tariff Impact
Indian MSMEs request loan moratorium & faster payments in pre-Budget meet. Textiles, gems sectors hit hardest by US tariffs. Govt approves ₹25,060 cr export mission.
Govt directs PSBs to ramp up MSME, agriculture lending
Finance Ministry urges public sector banks to increase credit flow to MSMEs and agriculture while maintaining strong risk management and digital expansion. Key initiatives reviewed.
NML Jamshedpur Hosts Workshop on Corrosion-Resistant Coatings
CSIR-National Metallurgical Laboratory organized a workshop for MSMEs on corrosion and wear-resistant coating technology. Learn how this enhances component life and industrial reliability.
₹45,060 Crore Export Boost Scheme Announced for MSMEs
Indian government unveils massive ₹45,060 crore scheme to boost exports, support MSMEs, and enhance global competitiveness. Key initiatives include interest equalization and TIES renewal.
Assocham Calls for Single-Window Reforms for MSMEs
New Assocham study demands urgent business regulation reforms and digitized single-window systems to transform India's MSME sector, contributing 33% to economy.
MSMEs Seek Finance, Tech Support in Pre-Budget Meet
MSME stakeholders presented key demands to Finance Minister Nirmala Sitharaman, including easier finance, delayed payment solutions, and tech adoption, ahead of the Union Budget 2026-27.
₹25,060 Crore Export Promotion Mission Gets Cabinet Nod
PM Modi's cabinet approves comprehensive export promotion mission with ₹25,060 crore budget to boost Indian exports facing global tariff challenges. Learn how this will benefit MSMEs.
Gujarat Pharma Factory Blast: 2 Dead, 20 Injured
Tragic boiler explosion at pharmaceutical factory in Gujarat's Bharuch district claims 2 lives, leaves 20 injured. Massive fire brought under control by emergency teams.
India's Drug Regulator Tightens Pharma Quality Control
India's DCGI orders nationwide inspections of small pharma units as WHO flags toxic cough syrups. MSMEs struggle to meet new Schedule M compliance deadline of January 2026.
Bajaj Finance stock plunges 8% amid MSME stress
Bajaj Finance shares fell 8% despite strong Q2 growth as elevated credit costs and MSME portfolio stress challenge valuations. Company lowers FY26 AUM guidance.
Indian Pharma Units Face Closure Over GMP Non-Compliance
DCGI directs state authorities to enforce strict GMP compliance by December 31, 2025. Delhi, Himachal Pradesh, Uttarakhand already taking action against non-compliant manufacturers.
DCGI Orders Global Pharma Standards Implementation by Jan 2026
India's drug regulator DCGI mandates global manufacturing standards for all pharma companies by January 2026. State regulators ordered to begin inspections immediately. Read about the strict compliance requirements.
Sun Pharma: US Tariff Clarity & Q2 FY26 Outlook
Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.
Indian Pharma Soars with Record US Generic Drug Profits
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
Sitharaman Unveils Banking Reforms & AI Regulation
Finance Minister Nirmala Sitharaman announces transformative banking reforms, AI regulation framework, and GST simplification to fuel India's economic growth at SBI Conclave.
AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma Bets on US Biopharma Funding Revival
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
Solara Pharma Q2 Loss: ₹10 Crore Amid Challenges
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
Sun Pharma Q2 Profit Rises 2.5% to ₹3,118 Crore
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
Navin Fluorine Shares Surge 22% in 3 Sessions
Discover why Navin Fluorine International shares skyrocketed 22% in just three trading sessions. Expert analysis reveals the key drivers behind this chemical sector powerhouse's impressive rally and what investors should watch next.
Q2 Results Today: Sun Pharma, Grasim, Britannia Earnings
Market eyes Wednesday's Q2 earnings bonanza as pharma giant Sun Pharma, Grasim Industries, and FMCG major Britannia declare results. Get complete analysis and investor expectations.
PNB MetLife Launches 360 Biz Digital Platform for MSMEs
PNB MetLife unveils groundbreaking 360 Biz digital platform, transforming insurance accessibility for India's MSME sector with comprehensive digital solutions.
Jharkhand MSME Bill 2025: 26 Compliance Burdens Axed
Jharkhand Governor CP Radhakrishnan approves groundbreaking MSME Special Exemption Bill 2025, eliminating 26 compliance burdens to accelerate industrial growth and ease of doing business in the state.
Indian Bank MD Backs Jharkhand's Economic Growth
Indian Bank's Managing Director Binod Kumar commits to accelerating Jharkhand's economic development through enhanced banking services, digital transformation, and robust credit support for key sectors.
RegisterKaro Simplifies Pvt Ltd Company Registration
Discover how RegisterKaro is transforming the business landscape by making Private Limited company registration completely paperless, fast, and hassle-free for Indian entrepreneurs.
3 Hot Stocks: Grasim, Aurobindo Pharma, City Union Bank
Religare Broking's Ajit Mishra reveals 3 promising stocks for short-term gains. Discover technical analysis and price targets for Grasim, Aurobindo Pharma, and City Union Bank in this exclusive market insight.
Hot Stocks: Oil India, Aurobindo Pharma, Latent View Analysis
Get expert stock market insights from Jigar Patel of Anand Rathi as he reveals why Oil India, Aurobindo Pharma, and Latent View Analytics present compelling short-term opportunities for Indian investors.
J&K LG Pushes MSME & Startup Funding Boost
Lieutenant Governor Manoj Sinha calls for urgent financial support for MSMEs and startups in Jammu & Kashmir to drive economic growth and job creation.
3-Day GST Registration for Small Businesses in India
Indian government introduces revolutionary 3-day GST registration for small and low-risk businesses, streamlining compliance and boosting ease of doing business across the nation.
Page 3 of 4